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ABSTRACT
Aim: To assess whether low concentrations of a
fluorescent dye such as Rhodamine 6G would help the
unaided human eye visualise the vitreous and the internal
limiting membrane (ILM) under standard halogen illumi-
nation.
Material/methods: The UV/Vis absorption (E) and
fluorescence (I) spectra of Rhodamine 6G in water were
measured and compared with Indocyanine Green (ICG).
Surgery was performed in two rhesus monkeys and
consisted of standard pars plana vitrectomy with halogen
light source used for illumination. Rhodamine 6G was
diluted in balanced salt solution (BSS). A few drops of the
dye in a concentration of 0.1% (307 mOsm) were applied
over the posterior pole in the air-filled globe and washed
out by irrigation after 1 min. Immediately after surgery,
the globes were enucleated, fixated and prepared for
histological evaluation.
Results: In contrast to ICG, both the maximum of the
absorption and emission of Rhodamin 6G are very much
within the spectral sensitivity of the human eye. The
Rhodamine 6G–BSS itself appears red in colour. Using a
dye concentration of 0.1%, there was no visible red-
staining of the ILM as such. As the dye was irrigated out
with BSS, a marked green fluorescence of the fluid within
the vitreous cavity was noted. With halogen illumination
through a standard 20-gauge light pipe, the dye provided
a sufficient green fluorescence to identify and safely
remove the ILM and to clearly differentiate areas of
peeled from non-peeled ILM. During light microscopy,
eyes revealed a peeled ILM demarcation with no signs of
acute retinal toxicity.
Conclusion: The findings indicate that a fluorescent dye
can be used for ILM peeling. Assuming that the
fluorophore provides a high enough fluorescence quantum
yield after adsorption to the ILM, much lower dye
concentrations could be used compared with absorbent
dyes, thereby minimising toxic effects.
Vital dyes help to visualise nearly transparent
structures such as the internal limiting membrane
(ILM) and epiretinal membranes (ERM) and there-
fore facilitate their removal. Indocyanine Green
(ICG) was among the first dyes to be introduced
for ILM staining in macular hole surgery,1 but
potential toxic effects were noted shortly there-
after.2 3 With respect to the potential toxicity and
the narrow safety margin, the applicability of ICG
seems to be limited. Another dye, Trypan Blue,
was introduced for epiretinal membrane staining4
and provides only a weak contrast at the level of
the ILM. Brilliant Blue was suggested very recently
to stain ILM as well.5 However, all dyes have in
common that the contrast on the retinal surface is
obtained by light absorption of the dye. Another
option may be to use dye fluorescence. To further
evaluate the concept of fluorescence staining, we
performed a small proof-of-principle study in two
primates (Rhesus monkey) using Rhodamine 6G, a
dye that was shown to strongly stain the lens
capsule.6 Therefore, we were confident that
Rhodamine 6G would also stain the ILM, another
yet thinner basement membrane. In vivo experi-
ments performed by our group revealed dose-
dependent toxic effects of Rhodamine 6G.7 We
also wanted to compare the light absorption (and
emission) of Rhodamine 6G with the light absorp-
tion of ICG, a dye that is still in use for ILM
staining.
MATERIAL AND METHODS
The UV/Vis absorption (E) of IGG as well as the
UV/Vis absorption (E) and emission (I) spectra of
Rhodamine 6G (Sigma-Aldrich, St. Louis, MO, RN
989-38-8, CI 45160) in water was compared with
the normalised spectral sensitivity (I) of the human
eye (according to CIE 1924 (8) I) and the normal-
ised spectral characteristic of radiation of a
tungsten halogen lamp (3200 K, I). The following
spectrometers were used: Varian Cary 5000 for
UV/Vis absorption spectra and Perkin Elmer FS
3000 Fluorescence Spectrometer totally corrected.
Two rhesus monkeys were used for this inves-
tigation. Surgery was performed in one eye; the
fellow eye served as a control. The animals received
veterinary care in compliance with the ‘‘Guide for
the care and use of laboratory animals,’’ and the
procedures were approved by the institutional
ethics committee (IMM Recherche, Paris).
Ophthalmic surgery consisted of a standard pars
plana vitrectomy using a standard 20 gauge system
with a halogen light pipe (Alcon, Accurus). The
procedure was initiated by the injection of a
triamcinolone suspension (Kenacort, Bristol-
Myers Squibb, Paris) into the vitreous cavity to
allow for a reliable induction of PVD and thorough
removal of the vitreous. Before the injection into
the eye, the preservative benzyl alcohol-containing
vehicle had been aspirated and discarded. The
remaining triamcinolone crystal suspension at the
bottom of the glass phial was aspirated and diluted
with 0.9 ml of balanced salt solution (BSS) (Alcon,
Fort Worth, TX). Approximately 0.1 ml of this
triamcinolone suspension was then injected into
the eye.
Rhodamine 6G powder was dissolved and
diluted in BSS. A few drops of the dye in a
concentration of 0.1% (307 mOsm) were applied
over the posterior pole in the air filled globe and
washed out by irrigation after 1 min. Then, the
halogen light source was aimed at the retinal
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surface. ILM peeling was performed using end-gripping forceps.
Immediately after surgery, the globes were enucleated, fixated
and prepared for histological evaluation. Specimens were
examined using a magnification of 4006.
RESULTS
The maximum of absorption of ICG is in the near infrared
(NIR) at 779.0 nm and not within the spectral sensitivity of the
human eye (maximum at 555 nm) (fig 1).
For Rhodamin 6G, both the maximum of the absorption and
emission are very well within the spectral sensitivity of the
human eye (maximum absorption at 526.6 nm with a shoulder
at 500 nm and maximum of fluorescence (emission) at
552.0 nm). The small Stokes shift allows the efficient use of
the radiation of tungsten halogen lamp for illumination (fig 2).
The Rhodamine 6G–BSS itself shows a red colour. Using a dye
concentration of 0.2%, there was no visible red-staining of the
ILM as such. However, during the removal of the dye by
irrigation, a marked green fluorescence of the fluid within the
vitreous cavity was noted (fig 3). When aiming the halogen light
source on the surface of the retina, we observed sufficient green
fluorescence to identify and safely remove the ILM. The
contrast between areas of peeled and unpeeled retinal surface
was very pronounced (fig 4).
Light microscopy of the enucleated eyes revealed a well-
preserved ILM in most regions of the retina with no signs of
acute toxic reaction. In the region of the peeled retinal surface,
the ILM and some of the ganglion cell layer was partially
removed. The histological appearance, however, was limited to
mechanical alterations (fig 5). No toxic side effects were noted
in these regions, indicating that the observed morphological
alterations are likely the result of a mechanical trauma and not
related to the dye itself.
DISCUSSION
ICG is not an optimal dye for staining because the majority of
its absorption is in the NIR; therefore, a relatively high dye
concentration for staining is required, influencing the safety
margin of ICG. In contrast, the absorption and fluorescence
spectra of Rhodamine 6G are a good compromise for visual
applications because the fluorescence spectrum matches the
Figure 1 UV/Vis absorption (E) of Indocyanine green (ICG) (blue line)
compared with the human visual spectrum (400–700 nm) (magenta line
according to CIE 1924 (4a), I). The maximum absorption of ICG was at
779.0 nm absorption in water. Maximum sensitivity of human eye:
555 nm; l= wavelength.
Figure 2 UV/Vis absorption (black line, left, E) and fluorescence (black
line, right, I) spectra of Rhodamine 6G in water compared with the
normalised spectral sensitivity of the human eye (magenta line according
to CIE 1924 (4a), I) and the normalised spectral characteristic of radiation
of a tungsten halogen lamp (white line, 3200 K, I). For Rhodamine 6G, the
maximum absorption is measured at 526.6 nm with a shoulder at
500 nm and maximum of fluorescence (emission) at 552.0 nm;
l= wavelength.
Figure 3 Visualisation of the green fluorescent dye in the vitreous
cavity during irrigation.
Figure 4 Peeling of the green fluorescent the internal limiting
membrane (ILM) using end-gripping forceps. The area where the ILM has
already been removed can be easily identified (black star). The black
arrow indicates the demarcation line between peeled and unpeeled ILM.
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spectral sensitivity of human eye8 quite well in the bath-
ochromic region. In an investigation published recently,7 we
evaluated the safety profile of Rhodamine 6G in an animal
model. We found a dose-dependent toxic effect seen by a
significant decrease in retinal ganglion cell (RGC) counts after
intravitreal application of Rhodamine at concentrations of 0.2%
and 0.5%. This effect was most pronounced for concentrations
of 0.5% (mean 1393 (SEM 232) cells/mm2, as compared with
BSS control group 2269 (34) cells/mm2; p,0.0001). Injections
with lower concentrations (0.0002%, 0.002% and 0.02%) did
not lead to statistically significant retinal ganglion cell loss.
ERGs did not show any adverse effects, even at the highest
concentrations of Rhodamine 6G on rods, kinetics of rhodopsin
recovery after bleaching or cone-driven responses as compared
with controls.
Fluorescence is an optical phenomenon, in which the
molecular absorption of a photon triggers the emission of
another photon with a longer wavelength. The fluorescence
quantum yield describes the efficiency of the fluorescence
process and is defined as the ratio of the number of photons
emitted to the number of photons absorbed. Competing light is
only caused by scatter and may be excluded with filters. The
genuine fluorescence of human tissue becomes negligible for
radiation in the visible. In theory, the fluorescence spectrum of
dyes being suitable for intraocular fluorescent staining should
match the sensitivity of the human eye, and the absorption
should efficiently convert the light of easily accessible light
sources for excitation.
Fluorescence had previously been used to visualise the
vitreous. Yao and associates9 evaluated the efficacy and safety
of orally administered sodium fluorescein to stain the clear
vitreous before vitrectomy for proliferative diabetic retinopathy
(PDR) and showed a marked staining of clear vitreous by
sodium fluorescein administered 12–16 h before surgery. In PDR
patients, the staining effect seemed to be variable, and no such
staining effect was seen in patients with proliferative vitreor-
etinopathy, indicating that this approach is only applicable in
patients with breakdown of the blood–retina barrier. Although
no side effects were seen in this study on 27 individuals, one
drawback may still be the systemic application of fluorescein.
Others injected fluorescein directly into the vitreous cavity for
the same purpose.10
However, there are no reports on the use of fluorescent dyes
to visualise other structures at the vitreoretinal interface. In
the present proof-of-principle study, we were able to
demonstrate that ILM peeling can be performed using a
fluorescent dye. We conclude that the concept of ILM peeling
using a fluorescent dye may point to another class of dyes
being applicable for intraocular surgery. In our experiments,
the green fluorescence of Rhodamine 6G was strong enough to
visualise the ILM using a common halogen light source. We
observed no acute dye-related toxicity in this experiment.
Interestingly, there were marked alterations of the inner
retinal layers in the area of peeled ILM seen in histological
specimens of enucleated eyes. We do not believe that this is
attributed to a toxic effect of the Rhodamine 6G itself, as
adjacent areas of unpeeled ILM, which also came into contact
with the dye, appeared unremarkable. We hypothesise that
the observed histological alterations could be related to a
mechanical trauma: as proposed for ICG,11 the adsorption of
Rhodamine 6G into the tissue may result in an increase in
protein cross-linking and cause the ILM to be more adherent
to the underlying structures, leading to ganglion layer damage
as described in our present report. Large amounts of cellular
debris at the retinal side of the ILM seen after ICG-assisted
vitrectomy3 seem to underline this hypothesis. However, as
such morphological alterations are not necessarily associated
with unfavourable functional outcome of dye assisted
vitrectomy,3 the clinical relevance of an increased rigidity of
the ILM in terms of functional deficits (visual acuity, visual
field, etc) remains speculative.
The application of fluorescent dyes to visualise the vitreor-
etinal interface implies certain advantages compared with
absorbent dyes as used at present: assuming that the
intraoperatively used fluorophore shows a high enough fluor-
escence quantum yield after having adsorbed to the ILM, with
the stained structures emitting light while no light is emitted
from non-stained material, much lower dye concentrations
compared with absorbent dyes could theoretically be used
during intraocular surgery. Using this approach, the concentra-
tion of such a fluorescent dye could be potentially reduced far
beyond toxic levels.
Due to potential toxic effects of Rhodamine 6G in higher
concentrations,6 7 we do not recommend this dye for ILM
staining in humans. In addition, this study was primarily
performed to assess the staining properties of the dye and
immediate toxic effects, as eyes were enucleated immediately
following surgery. Therefore, our approach does not represent a
survival surgery, for example allowing 12–24 h for apoptosis to
occur. Longer-term retinal toxicity had been addressed in our
previous work.7
Nevertheless, Rhodamine 6G appeared to be a valuable dye
for this proof-of-principle investigation. As we have seen a dose-
dependent toxicitity of Rhodamine 6G as mentioned above, we
will now further evaluate the fluorescence of the ILM using
lower concentrations of Rhodamine 6G. In addition,
Rhodamine 6G will serve as a reference when investigating
the safety profile and staining properties of other Rhodamine
dyes as well as other known and newly synthesised fluorescent
dyes with a high biocompatibility and appropriate staining
characteristics.
Figure 5 Light micrograph of the retina at the rim of the internal limiting
membrane peeling. The semithin section was stained with Toluidine
Blue. Note the normal appearance in untreated regions (left side of
arrow). The peeling region shows loss of the ganglion cell layer (right
side of arrow) but otherwise no tissue reaction. Specimens were
examined using a magnification of 4006.
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